Antimicrobial use and bacterial resistance in neonatal patients

Area of Science:

• Neonatalogy
• Infectious Diseases
• Pharmacology

Background:

• Neonates, especially premature infants, are highly susceptible to infections.
• Prolonged hospital stays in neonatal intensive care units (NICUs) often lead to multiple antibiotic courses.
• Limited antibiotic options and unique physiological factors in neonates complicate treatment.

Purpose of the Study:

• To highlight the critical need for precise antibiotic management in neonates.
• To emphasize the importance of considering pharmacokinetic changes in this population.
• To underscore the role of healthcare professionals in combating antimicrobial resistance.

Main Methods:

• Review of current literature on neonatal infections and antibiotic use.
• Analysis of pharmacokinetic considerations in premature infants.
• Discussion of antimicrobial stewardship principles in the neonatal setting.

Main Results:

• Neonates require carefully adjusted antibiotic dosing due to evolving pharmacokinetic parameters.
• Antimicrobial resistance is a significant concern in this vulnerable population.
• Effective monitoring by neonatal nurses is essential for optimizing antibiotic therapy.

Conclusions:

• Optimizing antibiotic regimens in neonates is vital for patient outcomes.
• Vigilant monitoring and stewardship are key to mitigating risks associated with antibiotic use in neonates.
• Neonatal nurses play a crucial role in ensuring appropriate antimicrobial administration and surveillance.